NeuroSense Therapeutics (NRSN) Payables (2020 - 2026)
NeuroSense Therapeutics (NRSN) recorded Payables of $729,000 in Q2 2026, down 33.3% from $1.09 million a year earlier.
Powered by 
Analysis
NeuroSense Therapeutics (NRSN) Payables (2020 - 2026) Analysis & Trends
At the end of FY2025, NeuroSense Therapeutics reported Payables of $799,000, down 31.1% from FY2024.
- Annual Payables has a five-year compound annual growth rate of 70.8% (FY2020 to FY2025).
- Across earlier years, Payables came in at $1.16 million in FY2024 (-20.5%), $1.46 million in FY2023 (+193.0%), $498,000 in FY2022 and $39,000 in FY2021 (-29.1%).
- The Q2 2026 figure is the lowest quarterly Payables since Q1 2023.
- On a year-over-year basis, Payables rose in 1 of the last five quarters, with an average decline of 11.8%.
- Peak year-over-year performance for Payables in the last five years was growth of 808.3% in Q2 2023, against a decline of 33.3% in Q2 2026 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 7.03 Bn |
| 10 | NeuroSense Therapeutics | 3.97 Mn | -469,023.95 | - | 729,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 729,000.00 |
| Dec 31, 2025 | 799,000.00 |
| Jun 30, 2025 | 1.09 Mn |
| Dec 31, 2024 | 1.16 Mn |
| Sep 30, 2024 | 1.39 Mn |
| Jun 30, 2024 | 1.48 Mn |
| Mar 31, 2024 | 2.38 Mn |
| Dec 31, 2023 | 1.46 Mn |
| Sep 30, 2023 | 913,000.00 |
| Jun 30, 2023 | 1.09 Mn |
| Mar 31, 2023 | 419,000.00 |
| Dec 31, 2022 | 498,000.00 |
| Sep 30, 2022 | 206,000.00 |
| Jun 30, 2022 | 120,000.00 |
| Mar 31, 2022 | 180,000.00 |
| Dec 31, 2021 | 65,000.00 |
| Dec 31, 2020 | 55,000.00 |
API Access
NeuroSense Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=NRSN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "NRSN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=NRSN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();